Vir Biotechnology Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Marianne De Backer
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.3yrs |
| Board average tenure | 6.9yrs |
Recent management updates
Recent updates
CEO
Marianne De Backer (54 yo)
less than a year
Tenure
Dr. Marianne De Backer, MSc, Ph. D., MBA, served as Independent Director at Kronos Bio, Inc. from January 25, 2021 to June 2023. Dr. De Backer is Executive Vice President, Head of Global Business Developme...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive VP & Chief Technology Officer | 2.8yrs | US$3.58m | 0.011% MX$ 2.4m | |
| Executive VP & Chief Medical Officer | 5yrs | US$4.39m | 0.039% MX$ 8.9m | |
| CEO & Director | less than a year | no data | no data | |
| Co-Founder & Scientific Advisor | 7.9yrs | US$177.66k | no data | |
| Co-Founder & Scientific Advisor | 7.9yrs | no data | no data | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Executive VP & CFO | less than a year | no data | no data | |
| Executive VP & Chief Scientific Officer | less than a year | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Executive VP | 1.3yrs | no data | no data | |
| Vice President of Corporate Communications | no data | no data | no data | |
| Executive VP & Chief Human Resources Officer | less than a year | no data | no data |
1.3yrs
Average Tenure
53.5yo
Average Age
Experienced Management: VIR *'s management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | no data | no data | |
| Co-Founder & Scientific Advisor | 4.9yrs | US$177.66k | no data | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Independent Director | 7.7yrs | US$444.94k | 0.44% MX$ 99.8m | |
| Independent Director | 7.3yrs | US$464.94k | 0.029% MX$ 6.5m | |
| Independent Chairman | 7yrs | US$488.21k | 0.98% MX$ 219.7m | |
| Independent Director | 6.9yrs | US$454.94k | 0.18% MX$ 40.4m | |
| Director | 6.9yrs | US$7.48m | 2.78% MX$ 625.3m | |
| Scientific Advisor | 4.9yrs | US$23.92k | no data | |
| Independent Director | 6.9yrs | US$451.10k | 0.012% MX$ 2.6m | |
| Independent Director | 4.3yrs | US$459.94k | 0.0079% MX$ 1.8m |
6.9yrs
Average Tenure
63yo
Average Age
Experienced Board: VIR *'s board of directors are considered experienced (6.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/11 14:47 |
| End of Day Share Price | 2023/09/13 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vir Biotechnology, Inc. is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Madhu Kumar | Baird |
| Huidong Wang | Barclays |
| Alec Stranahan | BofA Global Research |